The
genetic
differences
human
papilloma
virus
(
HPV
)
-positive
-negative
head
neck
squamous
cell
carcinomas
(
HNSCC
)
remain
largely
unknown
.

To
identify
differential
biology
novel
therapeutic
targets
entities
,
determined
mutations
copy-number
aberrations
large
cohort
locoregionally
advanced
HNSCC
.

